Serum β 2-microglobulin may be a viral biomarker by analyzing children with upper respiratory tract infections and exanthem subitum: a retrospective study
- PMID: 33868812
- PMCID: PMC8034339
- DOI: 10.7717/peerj.11109
Serum β 2-microglobulin may be a viral biomarker by analyzing children with upper respiratory tract infections and exanthem subitum: a retrospective study
Abstract
Background: Due to the lack of effective and feasible viral biomarkers to distinguish viral infection from bacterial infection, children often receive unnecessary antibiotic treatment. To identify serum β2-microglobulin that distinguishes bacterial upper respiratory tract infection from viral upper respiratory tract infection and exanthem subitum in children.
Methods: This retrospective study was conducted from January 1, 2019 to September 30, 2020 in Yancheng Third People's Hospital. Children with upper respiratory tract infection and exanthem subitum were recruited. The concentration of serum β2-microglobulin in the viral and bacterial infection groups were statistically analyzed.
Results: A total of 291 children included 36 with bacterial upper respiratory tract infection (median age, 13 months; 44.4% female), 197 with viral upper respiratory tract infection (median age, 12 months; 43.7% female) and 58 with exanthem subitum (median age, 13 months; 37.9% female). When the concentration of β2-microglobulin was 2.4mg/L, the sensitivity to distinguish viral from bacterial upper respiratory tract infection was 81.2% (95% CI [75.1-86.4%]), and the specificity was 80.6% (95% CI [64.0-91.8]%). When the cutoff was 2.91 mg/L, the sensitivity of β2-microglobulin to distinguish exanthem subitum from bacterial upper respiratory tract infection was 94.8% (95% CI [85.6-98.9]%), and the specificity was 100% (95% CI [90.3-100]%).
Conclusions: Serum β2-microglobulin may be a significant biological indicator in children with upper respiratory tract infection and exanthem subitum.
Keywords: Exanthem subitum; Serum β2-microglobulin; Upper respiratory tract infections; Viral biomarker.
©2021 Cai et al.
Conflict of interest statement
The authors declare there are no competing interests.
Figures


Similar articles
-
Distribution characteristics of serum β2-microglobulin between viral and bacterial lower respiratory tract infections: a retrospective study.PeerJ. 2020 Aug 25;8:e9814. doi: 10.7717/peerj.9814. eCollection 2020. PeerJ. 2020. PMID: 32904447 Free PMC article.
-
[How often can the clinical diagnosis of exanthema subitum be confirmed with the HHV-6 serology test].Klin Padiatr. 1991 Mar-Apr;203(2):109-12. doi: 10.1055/s-2007-1025410. Klin Padiatr. 1991. PMID: 1851907 German.
-
Human herpesvirus 7: another causal agent for roseola (exanthem subitum).J Pediatr. 1994 Jul;125(1):1-5. doi: 10.1016/s0022-3476(94)70113-x. J Pediatr. 1994. PMID: 8021757
-
[Infections with herpesvirus 6--really only "exanthema subitum"? Part 1: More frequent disease pictures].Fortschr Med. 1992 Nov 20;110(32):599-603. Fortschr Med. 1992. PMID: 1335952 Review. German.
-
[New knowledge of Zahorsky exanthema subitum (critical 3-day fever-exanthema, roseola infantum].Kinderarztl Prax. 1989 Apr;57(4):155-62. Kinderarztl Prax. 1989. PMID: 2661896 Review. German.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources